Lathika Mohanraj obtained her Ph.D in Biochemistry and Cellular Biology from Virginia Commonwealth University, Richmond, Virginia USA. Her doctoral work was primarily on human Mouse Double Minute-2 (MDM-2) and the NF-κB2 pathway in human lung cancer. She is currently a post-doctoral fellow in the Department of Pathology at Virginia Commonwealth University. Her current research focus is to study the role of Insulin-like Growth Factor Binding Protein-3 (IGFBP-3) in cardiovascular diseases and metabolic syndrome as a whole gearing towards a potential therapeutic role of IGFBP-3 in various aspects of metabolic syndrome. She also serves as the President of the VCU Post-Doctoral Association.

Dr. Mohanraj has published 6 peer-reviewed research works and presented at many institutional, national and international conferences. She was also selected by the Jawaharlal Nehru Center for Advanced Scientific Research, Bangalore, India for a Training fellowship program to research at the Institute of Microbial Technology, Chandigarh, India. She was awarded a National Scholarship by the Government of India for her academic excellence in her undergraduate program.

Mohanraj L. and Oh Y. Impact of IGF system on dietary short chain fatty acid-induced anti-inflammatory and anti-tumor effects.Biomedical Research 2012; 23: SI 187-195 (2012)

Vaughan C.* , Mohanraj L*, Singh S., Dumur C.I., Ramamoorthy M., Garrett C.T., Ramakrishnan V., Windle B., Yeudall A., Deb S. and Deb S.P. Human oncoprotein MDM2 up-regulates expression of NF-κB2 precursor p100 conferring survival advantage to lung cells.

Genes Cancer. 2011 Oct;2(10):943-55. (* Equal contribution) (2011)

Mohanraj L and Oh Y. Targeting IGF-I, IGFBPs and IGF-I Receptor System in Cancer: The Current and Future in Breast Cancer Therapy. Recent Pat Anticancer Drug Discov. 2011, May 1;6(2):166-77. (2011)

Ingermann AR, Yang YF, Paisley TE, Han J, Mikami A, Garza AE, Mohanraj L, Fan L, Idowu M, Ware JL, Kim HS, Lee DY, Oh Y. Identification of a novel cell death receptor mediating IGFBP-3-induced antitumor effects in breast and prostate cancer. J Biol Chem. (2010)

Frum R, Ramamoorthy M, Mohanraj L, Deb S, Deb S.P. MDM2 controls the timely expression of cyclin A to regulate cell cycle. Mol Cancer Res. 2009 Aug; 7(8):1253-67. Epub 2009 Aug 11.(2009)

*Scian MJ, Carchman EH, *Mohanraj L, Stagliano KE, Anderson MA, Deb D, Crane BM, Kiyono T, Windle B, Deb SP, Deb S. Wild-type p53 and p73 negatively regulate expression of proliferation related genes. Oncogene. 2008 Apr 17; 27(18):2583-93. Epub 2007 Nov 5. (* Equal contribution) (2008)